Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALLNeoplasm, Residual, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasmNot yet recruitingNot applicable2025-01-08NCT06763302

1 results · Page 1 of 1

Swipe the table sideways for more columns.

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
No products are listed yet.